Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Novel drug target identified for hepatitis B

Sep. 27, 2000

Zefix approved in Japan for chronic HBV infection

Sep. 26, 2000

Valentis and Viragen combine PEGylation technology and Omniferon for HCV therapy

Sep. 25, 2000

Therapeutically useful M3/5-HT4 antagonists patented by major French lab

Sep. 19, 2000

Highly potent motilin antagonists reported by Chugai

Sep. 19, 2000

Long-term therapy with entecavir assessed in woodchuck model of chronic HBV infection

Sep. 18, 2000

HEV vaccine technology licensed to SmithKline Beecham

Sep. 15, 2000

Rabeprazole superior to ranitidine in erosive gastroesophageal reflux disease

Sep. 15, 2000

Safety study of anti-hepatitis C ribozyme compound completed

Sep. 14, 2000

Metformin completely reverses fatty liver in mouse model

Sep. 13, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...